Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis

Journal of Physiology and Pharmacology

Volumn 48, Issue 3, 1997, Pages 365-373

  Konturek, P Ch ^b   Konturek, S J ^a   Bobrzynski A ^a   Kwiecien N ^a   Obtulowicz W ^a   Stachura, J ^a   Hahn, E G ^b   Rembiarz, K ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Atropic gastritis; Duodenal ulcer; EGF; Gastric acid; Gastrin; TGF

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; EPIDERMAL GROWTH FACTOR; OMEPRAZOLE; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; GASTRIN BLOOD LEVEL; GENE EXPRESSION; HELICOBACTER PYLORI; HISTOCHEMISTRY; HUMAN; MALE; STOMACH ACID SECRETION; STOMACH MUCOSA;

ADULT; DUODENAL ULCER; EPIDERMAL GROWTH FACTOR; GASTRIC ACID; GASTRIC MUCOSA; GASTRIN-RELEASING PEPTIDE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0030820013     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Marshall BJ, Goodwin CS, Warren JR et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1237-1441.
2. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacrer pylori. Lancet 1990; 335: 1233-1235.
3. Hentschel E, Brandstatter G, Dragosics B et al. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
4. McColl KEL, Fullarton GM, Chittajallu R et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339-346.
5. Prewett EJ, Smith JTL, Nwokolo CU, Hudson M, Sawyer AM, Pounder RE. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991; 5: 283-290.
6. Levi S, Beardshall K., Swift I et al. Antral Helicobacter pylori, hypergastrinaemia and duodenal ulcers: effect of eradicating the organism. BMJ 1989; 299: 1504-1505.
7. Graham DY, Opekun A, Lew GM, Evans DJ, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990: 85: 394-398.
8. El-Omar EM, Penman ID, Ardill JES, Chittajally RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691.
9. Levi S, Haddad G, Ghosh P, Beardshall K, Playford R, Calam J. Campylobacter pylori and duodenal ulcer: the gastrin link. Lancet 1989; 1: 1167-1168.
10. Konturek JW, Bielariski W, Konturek SJ, Domschke W. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J Physiol Pharmacol 1996; 47: 161-175.
11. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975: 257: 325-327.
12. Konturek JW, Bielański W, Konturek SJ, Bogdał J, Oleksy J. Distribution and release of epidermal growth factor in man. Gut 1989; 30: 1194-1200.
13. Polk WH, Dempsey PJ, Russel WE et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992; 102: 1467-1474.
14. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor - related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995; 108: 564-580.
15. Konturek PC, Ernst H, Konturek SJ, Hahn EG. Mucosal expression and luminal release of epidermal growth factor and transforming growth factor in duodenal ulcer patients before and after eradication of Helicobacter pylori. Gut 1997; 40: 463-469.
16. Nomura A, Stemmermann GN. Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. NJE Med 1991; 325: 1132-1136.
17. Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302-1305.
18. Lynch DAF, Mapstone NP, Clarke AMT et al. Cell proliferation in Helicobacter pylori associated gastritis and the affect of eradication therapy. Gut 1995; 36: 346-350.
19. Caghill RJ, Xia H, Kilgallen C, Beattle S, Hamilton S, O'Marion C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995; 40: 1627-1631.
20. Thomsen LL, Gavin JB, Tasman-Jones C. Relation of Helicobacter pylori to human gastric mucosa in chronic gastritis of the antrum. Gut 1990; 31: 1230-1236.
21. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995; 37: 482-487.
22. McColl KEL, El-Omar EE. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol 1996; 31 (Suppl 215): 33-37.